Published on: Jun 6, 2022 4:33:06 PM by SVA Life Sciences
Updated on: August 5, 2024
SVA Life Sciences is proud to announce the firm will be an exhibitor at the 2022 World Orphan Drug Congress held on July 11-13, 2022 in Boston.
The World Orphan Drug Congress brings together leading pharmaceutical and biotech companies, government and regulatory authorities, patient advocacy groups, payers, investors, and solution providers. The conference is a place to meet and brainstorm ways to advance orphan drug development and improve access to life-saving therapies.
Join SVA Life Sciences in Boston for the world’s most important orphan drug and rare disease event. Register today and receive a 50% discount as our guest.
About SVA Life Sciences
SVA Life Sciences helps biopharmaceutical, biotechnology, and diagnostic leaders navigate a successful commercialization roadmap – the launch of their product and the company that supports it either as a first-time launcher or a high-growth company experiencing constraints. Leaning on decades of expertise, the firm provides strategic partnership to clients in tackling the complex technical and professional challenges associated with business growth and transformation. They are inspired by the people in the life sciences industry and share their passion for the product journey and improving the lives of patients.
Share this post:
We help biopharmaceutical leaders navigate a successful commercialization journey - the launch of their product and the company that supports it.
